Shares of Baxter International Inc (NYSE:BAX) ended Thursday session in green amid volatile trading. The shares closed up +0.14 points or 0.30% at $47.39 with 4.30 million shares getting traded. Post opening the session at $47.43, the shares hit an intraday low of $47.37 and an intraday high of $47.75 and the price vacillated in this range throughout the day. The company has a market cap of $25.76 billion and the numbers of outstanding shares have been calculated to be 543.89 million shares.
On August 11, 2016 Baxter International (BAX) committed to innovative technology for medication delivery designed to enhance patient safety, and highlighted a report from KLAS that named the Sigma Spectrum Infusion System the leader among all large-volume infusion pumps in drug library compliance, overall ease-of-use and ease of navigating the drug library.1 Drug libraries allow clinicians to choose from a curated list of medications and fluids within medically appropriate dose ranges that helps identify potential programming mistakes before they reach the patient. Additionally, clinicians rated Sigma Spectrum highest in response to the question, ”How Well Does the Pump’s User Interface Contribute to Patient Safety?”
”The Sigma Spectrum Infusion System was designed from the ground-up with easy-to-use features that provide real-world value and prioritize patient safety and clinician efficiency,” said David Ferguson, Global Franchise Head of Baxter’s Fluid Systems franchise. ”These findings validate our design philosophy, and provide examples of why Sigma Spectrum has achieved the highest drug library compliance rate in the industry.”
KLAS is a research firm that specializes in monitoring and reporting the performance of software, services, and medical equipment vendors. Working with hundreds of thousands of healthcare executives from hospitals and clinics worldwide, KLAS collects performance feedback to deliver timely reports, trends and statistics that provide a solid overview of vendor performance in the industry. Their newest report, ”Smart Pumps 2016: The Quest for Patient Safety,” gathered input from end users—primarily nurses—on key features of infusion pumps that promote greater patient safety. These users credit Sigma Spectrum’s leading drug library compliance rate with how simple the pump is to use and update. The pump has a ”small learning curve” thanks to ”drug-library navigation—users are automatically logged in and can quickly and accurately find what they need—and the simple, strong design of the user interface, which includes the size of the screen and the numeric and graphic clarity.”
Shares of Abbott Laboratories (NYSE:ABT) ended Thursday session in red amid volatile trading. The shares closed down -0.10 points or -0.24% at $41.58 with 4.87 million shares getting traded. Post opening the session at $41.95, the shares hit an intraday low of $41.58 and an intraday high of $42.00 and the price vacillated in this range throughout the day. The company has a market cap of $60.85 billion and the numbers of outstanding shares have been calculated to be 1.47 billion shares.
On Sept. 20, 2016 While some endurance, strength and physique athletes try to minimize their intake of fat, others are embracing a high-fat, ketogenic nutrition plan. To help those athletes build stronger, leaner bodies and meet endurance goals, EAS Sports Nutrition is introducing a Myoplex Ketogenic shake.
A ketogenic regimen is high in fat, moderate in protein and very low in carbohydrates. The purpose of the regimen is to shift the body from relying on glucose for energy to instead tapping into stored fat. As the body breaks down more fats as a source of energy, this naturally results in formation of ketone bodies by the liver. The ketones enter the blood, referred to as ketosis, and then can be used as a fuel source by the body to replace some of the needs originally supplied by glucose.
Some studies have shown that a ketogenic plan can help increase fat burning during exercise1, mobilizing fat stores for energy use. Since the body can store more fat than glycogen, endurance, strength and physique athletes can potentially access those vast energy reserves without continually refueling with carbohydrates during exercise.
“The ketogenic diet has been around for many years and research suggests that certain types of athletes can achieve high levels of physical performance on the regimen,” said Steve Hertzler, PhD, RD, and chief scientific officer for EAS. “Myoplex Ketogenic delivers an optimal ratio of nutrients needed to maintain the regimen and help attain the desired benefits.”